The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer

The glucose metabolism reprogramming is a hallmark of cancer. The oncoprotein hepatitis B X-interacting protein (HBXIP) functions in the development of breast cancer. In this study, we supposed that HBXIP might be involved in the glucose metabolism reprogramming in breast cancer. We showed that HBXI...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Liu, Fabao, Zhang, Weiying, You, Xiaona, Liu, Yunxia, Li, Yinghui, Wang, Zhen, Wang, Yue, Zhang, Xiaodong, Ye, Lihong
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2015
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4694983/
https://ncbi.nlm.nih.gov/pubmed/26309161
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk